A class action has been filed against Boston Scientific Corporation (BSX), certain of its officers and directors by stockholders who purchased the company's common stock between March 31, 2003 and August 23, 2005. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.
According to a press release dated September 21, 2005, the complaint alleges that during the Class Period, Boston Scientific, a company that engages in the development and marketing of cardiovascular and endosurgery medical device products, and certain individual defendants violated provisions of the Securities and Exchange Act of 1934, causing its stock to trade at artificially inflated levels. Specifically, the complaint alleges that Boston Scientific provided highly explicit false and misleading assurances of the Company's ability to satisfy FDA regulations governing its medical device product quality, as well as affirmative representations as to the Company's knowledge and expertise regarding design, development, marketing approval and sales of its medical devices. The complaint further alleges over $400 million sold in insider trading.
The complaint further alleges that on or around August 23, 2005, based on the cumulative impact of three separate FDA Warning Letters, investors learned of defendants' broad-based concealment of its broken quality program and the risks the Company faced. As a result, Boston Scientific's stock price dropped $1.23, or 4.5% to $25.92, on volume of 15.8 million shares -- nearly $19.89 or 43.4% from its Class Period high of $45.81 on April 5, 2004.
If you bought Boston Scientific Corporation securities between March 31, 2003 and August 23, 2005, inclusive, and would like to obtain information about the Boston Scientific Corporation lawsuit, then you are invited to call (866) 467-1400 to speak with an attorney.